Individuals Coming Off Anti-Obesity Injections Gain Back Pounds Far More Rapidly Than Dieters

A recent study suggests that patients who stop using popular slimming jabs like semaglutide or tirzepatide can put back on reduced body mass at a significantly accelerated pace than those who halt traditional lifestyle regimens.

Published data in a prominent health publication points out that while obese individuals frequently drop about a fifth of their total mass while using the jabs, the weight returns at an estimated rate of nearly a kilo each month upon discontinuation.

"Users buying such treatments must be aware of the risk of fast rebound weight gain when the treatment ends," stated researcher Dr. Susan Jebb.

This pace of recovery suggests a reversion to original mass within about a year and a half.

Analyzing Approaches

The analysis, which looked at 37 of trials involving thousands of participants, compared the results of the injectable medications with other pills.

Researchers emphasize that individuals who shed pounds through dieting usually see a more gradual weight regain—perhaps 100 grams monthly—after stopping.

Explaining the Quick Rebound

Experts suggest the way of the jabs explains the heightened rebound.

GLP-1 drugs imitate a body's own chemical called glucagon-like peptide-1, which controls feelings of fullness.

"Sustained high doses of GLP-1 levels several times higher than normal could lead to the body to generate a reduced amount of its own natural hormone, and may also reduce responsiveness to its actions," noted Dr. Adam Collins, a nutrition researcher.

"Discontinuation of this GLP-1 'fix' means appetite is uncontrolled, making binge eating a significant risk."

A Lifelong Disease?

The NHS suggest the injections for people with obesity-related medical conditions, alongside recommended lifestyle changes.

Professionals contend that, considering the likelihood of weight regain, the treatment is often life-long.

This perspective is supported by drug manufacturers, who say that the findings "underscore the long-term nature of obesity," similar to managing diseases like hypertension.

Patient Accounts

Individuals who have discontinued the jabs describe a sudden resurgence of hunger.

"It felt as if a switch that goes on and I was suddenly starving," said a patient.

This challenge is compounded if patients have not adopted sustainable lifestyle or habit changes during treatment.

Significant Interest

Survey data show that a significant number of people in the UK have used these injections in the past year, with desire remaining high.

• Use is more common among females than men.
• The 40s and 50s age group shows the greatest level of interest.
• Many access the medications through private prescriptions rather than public health services.

In conclusion, experts stress that while these medications are powerful agents for weight loss, they are not a permanent fix and lasting health benefits relies on integrated lifestyle management.